-
Product Insights
House Dust Mite Allergy Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “House Dust Mite Allergy Disease - Global Clinical Trials Review, H2, 2020" provides an overview of House Dust Mite Allergy Clinical trials scenario. This report provides top line data relating to the clinical trials on House Dust Mite Allergy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points...
-
Sector Analysis
Sjogren’s Syndrome - Epidemiology Forecast to 2029
Sjögren’s syndrome (SS) is a chronic autoimmune disease, characterized by immune cells attacking and destroying the glands that produce tears and saliva (NIH, 2019). It results in two major clinical manifestations: keratoconjunctivitis sicca (dry eyes) and xerostomia (dry mouth), more broadly known as sicca syndrome (Arthritis Foundation, 2019). It can be classified into two types, primary and secondary SS. Primary SS (pSS) is seen in the absence of any other autoimmune disease (Salliot et al., 2007). Those most at risk...
-
Product Insights
Sarcoidosis Disease - Global Clinical Trials Review, H1, 2020
GlobalData's clinical trial report, “Sarcoidosis Global Clinical Trials Review, H1, 2020" provides an overview of Sarcoidosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Sarcoidosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Heart Transplant Rejection Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Heart Transplant Rejection Global Clinical Trials Review, H2, 2020" provides an overview of Heart Transplant Rejection Clinical trials scenario. This report provides top line data relating to the clinical trials on Heart Transplant Rejection. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Grass Pollen Allergy Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Grass Pollen Allergy Global Clinical Trials Review, H2, 2020" provides an overview of Grass Pollen Allergy Global Clinical Trials Review, H2, 2020 Clinical trials scenario. This report provides top line data relating to the clinical trials on Grass Pollen Allergy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
Myasthenia Gravis Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Myasthenia Gravis Global Clinical Trials Review, H2, 2020" provides an overview of Myasthenia Gravis Clinical trials scenario. This report provides top line data relating to the clinical trials on Myasthenia Gravis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Microscopic Polyangiitis (MPA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Microscopic polyangiitis is an ill-defined autoimmune disease characterized by a systemic, pauci-immune, necrotizing, small-vessel vasculitis without clinical or pathological evidence of necrotizing granulomatous inflammation. The signs and symptoms of microscopic polyangiitis may resemble those of granulomatosis with polyangiitis (GPA) (another form of small-vessel vasculitis) but lack the significant upper respiratory tract involvement frequently seen in people affected by GPA. The Microscopic Polyangiitis drugs in development market research report provides comprehensive information on the therapeutics under development for Microscopic Polyangiitis, complete...
-
Product Insights
Myasthenia Gravis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Myasthenia gravis is autoimmune neuromuscular disease characterized by weakness and rapid fatigue of any of the muscles under voluntary control. Symptoms include drooping of one or both eyelids, diplopia and difficulty swallowing, chewing and speaking. Treatment includes immunosuppressants, corticosteroids and surgery. The Myasthenia Gravis - Drugs In Development research report provides a comprehensive overview on the therapeutics under development for Myasthenia Gravis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and...
-
Product Insights
Systemic Sclerosis (Scleroderma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Scleroderma is a group of rare diseases that involve the hardening and tightening of the skin and connective tissues. Symptoms include muscle pains, joint pain and swelling, ulcers occurring on fingertips, bloating of the tummy and diarrhea or constipation. Treatment includes antibiotic, pain relievers and immunosuppressant. Global Markets Direct’s report features investigational drugs from across globe. The Systemic Sclerosis (Scleroderma) - Drugs In Development research report provides a comprehensive overview on the therapeutics  under  development  for  Systemic  Sclerosis  (Scleroderma),  complete  ...
-
Product Insights
House Dust Mite Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
House dust mite allergy is an allergic reaction to tiny bugs that commonly live in house dust. Symptoms include frequent sneezing, a runny, stuffy, itchy nose and irritated eyes. Asthma and eczema can also be triggered by a dust mite allergy. Symptoms often worsen when the individual comes in close proximity to disturbed dust. The House Dust Mite Allergy - Drugs In Development research report provides a comprehensive overview on the therapeutics under development for House Dust Mite Allergy, complete...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.